SELLAS Life Sciences announces settlement of counterclaims against JGB (Cayman) Newton, Ltd. for $6.6 million payment by JGB

Follows Dismissal by Court of All Claims Against SELLAS  Debenture and All Security Interests Held by JGB Terminated NEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company…